loadpatents
name:-0.012155055999756
name:-0.0038058757781982
name:-0.00057792663574219
Schuurman; Hendrik J. Patent Filings

Schuurman; Hendrik J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schuurman; Hendrik J..The latest application filed is for "use of rapamycin derivatives in vasculopathies and xenotransplantation".

Company Profile
0.3.10
  • Schuurman; Hendrik J. - Basel CH
  • Schuurman; Hendrik J. - Charlestown MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Rapamycin Derivatives In Vasculopathies And Xenotransplantation
App 20140187574 - Schuler; Walter ;   et al.
2014-07-03
Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
Grant 8,435,520 - Schuurman , et al. May 7, 2
2013-05-07
Use Of Rapamycin Derivatives In Vasculopathies And Xenotransplantation
App 20120177690 - Schuler; Walter ;   et al.
2012-07-12
Combinations Of Immunosuppressive Agents For The Treatment Or Prevention Of Graft Rejections
App 20110142953 - SCHUURMAN; Hendrik J. ;   et al.
2011-06-16
Use Of Rapamycin Derivatives In Chronic Rejection
App 20100152105 - Schuler; Walter ;   et al.
2010-06-17
Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections
App 20080199478 - SCHUURMAN; Hendrik J. ;   et al.
2008-08-21
Combinations of immunosupressive agents for the treatment or prevention of graft rejections
App 20070060511 - Schuurman; Hendrik J. ;   et al.
2007-03-15
Combinations of immunosupressive agents for the treatment or prevention of graft rejections
App 20050277585 - Schuurman, Hendrik J. ;   et al.
2005-12-15
Combinations of immunosupressive agents for the treatment or prevention of graft rejections
App 20020132764 - Schuurman, Hendrik J. ;   et al.
2002-09-19
Use of rapamycin derivatives in vasculop atheis and xenotransplantation
App 20020127248 - Schuler, Walter ;   et al.
2002-09-12
Use of 40-O-(2-hydroxy)ethylrapamycin for treatment of restenosis and other disorders
Grant 6,384,046 - Schuler , et al. May 7, 2
2002-05-07
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed